Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
- Status
- UNKNOWN
- Phase
- PHASE3
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Status
- RECRUITING
- Phase
- PHASE2
Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC
- Status
- SUSPENDED
- Phase
- PHASE3
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy
- Status
- TERMINATED
- Phase
- NA